Table 8.3. Tumor, node, metastasis (TNM) staging of gallbladder tumors
Primary tumor:
Tx |
Primary tumor cannot be assessed |
T0 |
No evidence of primary tumor |
Tis |
Carcinoma-in-situ |
T1a |
Tumor invades lamina propria |
Tlb |
Tumor invades muscle layer |
T2 |
Tumor invades perimuscular connective tissue; |
|
no extension beyond serosa or into liver |
T3 |
Tumor perforates serosa and/or invades liver |
|
and/or other adjacent organs |
T4 |
Tumor invades main portal vein or hepatic |
|
artery or multiple extrahepatic organs |
Lymph nodes:
Nx Regional nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Regional lymph node metastasis
Distant metastasis:
Mx Distant metastases cannot be assessed M0 No distant metastasis
M1 Distant metastasis
Tumor stages: |
|
|
|
Stage 0 |
Tis |
N0 |
M0 |
Stage IA |
T1 |
N0 |
M0 |
Stage IB |
T2 |
N0 |
M0 |
Stage IIA |
T3 |
N0 |
M0 |
Stage IIB |
T1 |
N1 |
M0 |
|
T2 |
N1 |
M0 |
|
T3 |
N1 |
M0 |
Stage III |
T4 |
any N |
M0 |
Stage IV |
any T |
any N |
M1 |
Source: From the AJCC Cancer Staging Manual, 6th edition (2002), published by Springer-Verlag, New York, NY, used with permission of the American Joint Committee on Cancer (AJCC), Chicago, IL.
tive; an extended cholecystectomy with lymph node dissection, at times combined with extrahepatic bile duct or hepatic resection, offers a possible cure. A 5-year survival of 10% to 15% is typical, with long-term survivors being stage
Table 8.4. Helical CT detection of gallbladder carcinoma
|
Sensitivity |
Specificity |
T1 |
33% |
94% |
T2 |
64–73% |
80% |
T3 |
80% |
81–88% |
T4 |
100% |
95% |
Source: Adapted from Yoshimitsu et al. (55).
ADVANCED IMAGING OF THE ABDOMEN
I or II. Aggressive surgery appears to improve survival. A University of Bonn (Germany) study of patients undergoing curative resection, consisting of an extended cholecystectomy (cholecystectomy with lymphadenectomy and wedge hepatic resection), anatomic segmentectomy of segments IVa and V, or extended hepatectomy, achieved an actuarial 5-year survival rate of 55% (56).
An endoprosthesis, placed either endoscopically or percutaneously, is useful for palliation in some patients with an unresectable carcinoma.
Chemotherapy has had little impact on survival.
Metastases/Recurrence
Gallbladder carcinomas metastasize widely, even to bone. Spread to extrahepatic bile ducts, gastrointestinal tract, and adjacent structures is common. Occasionally a distant metastasis is the first clue to an underlying gallbladder carcinoma. An exceptional patient with extensive metastases, treated aggressively has prolonged survival.
More than most cancers, gallbladder carcinoma spreads readily along laparoscopic trocar sites. A number of patients have an unsuspected carcinoma first detected by a pathologist, with trocar site recurrence identified several months later. Even several recurrences have developed at laparoscopic ports (57). Peritoneal seeding also occurs, including localized seeding in the right subphrenic space.
A suspected gallbladder carcinoma probably is a contraindication to laparoscopic cholecystectomy. When a laparoscopic cholecystectomy is performed for an unsuspected carcinoma, surgical and adjuvant radiotherapy to the trocar sites appears reasonable.
Computed tomography identifies port track recurrence as a homogeneous abdominal wall tumor, often directly involving adjacent omental fat (57). Recurrences tend to enhance markedly on postcontrast CT.
Other Primary Carcinomas/Sarcomas
Both squamous and adenosquamous gallbladder carcinomas are uncommon. Often a large tumor with invasion of adjacent structures is